Current Signal Transduction Therapy
Title:Meet Our Editorial Board Member
Volume: 11 Issue: 2
Author(s): Alex Almasan
Affiliation:
Export Options
About this article
Cite this article as:
Almasan Alex, Meet Our Editorial Board Member, Current Signal Transduction Therapy 2016; 11 (2) . https://dx.doi.org/10.2174/157436241102161110185029
DOI https://dx.doi.org/10.2174/157436241102161110185029 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
26
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Involvement of PI3K/Akt Pathway in Prostate Cancer - Potential Strategies for Developing Targeted Therapies
Mini-Reviews in Medicinal Chemistry The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems
Current Pharmaceutical Design Nanoscale Formulations and Diagnostics With Their Recent Trends: A Major Focus of Future Nanotechnology
Current Pharmaceutical Design 1, 25(OH)<sub>2</sub>D<sub>3</sub> Inhibits Hepatocellular Carcinoma Development Through Reducing Secretion of Inflammatory Cytokines from Immunocytes
Current Medicinal Chemistry Curcumin: Powerful Immunomodulator from Turmeric
Current Immunology Reviews (Discontinued) Adrenergic Receptors as Targets for Cancer Treatment - A Perspective for Future Studies
Current Cancer Therapy Reviews Biodiversity as a Source of Bioactive Compounds Against Snakebites
Current Medicinal Chemistry Radiolabeled Peptides and Proteins in Cancer Therapy
Protein & Peptide Letters Proteasome Inhibitors in Cancer Therapy
Current Drug Targets Exploration of Novel 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia by 2D/3D QSAR, Cytotoxicity Pre-ADME and Docking Studies
Current Topics in Medicinal Chemistry Long Term Prognosis in IgG4-Related Systemic Disease (ISD)
Current Immunology Reviews (Discontinued) Physiological Animal Imaging with <sup>68</sup>Ga-Citrate
Current Radiopharmaceuticals Biological Rationale for Regular Physical Exercise as an Effective Intervention for the Prevention and Treatment of Depressive Disorders
Current Pharmaceutical Design Resveratrol in Medicinal Chemistry: A Critical Review of its Pharmacokinetics, Drug-Delivery, and Membrane Interactions
Current Medicinal Chemistry Pathobiology and Prevention of Cancer Chemotherapy-Induced Bone Growth Arrest, Bone Loss, and Osteonecrosis
Current Molecular Medicine Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Polyethylenimine as a Promising Vector for Targeted siRNA Delivery
Current Clinical Pharmacology CXXC5 Associates with Smads to Mediate TNF-α Induced Apoptosis
Current Molecular Medicine Secretory Clusterin: A Promising Target for Chemoresistance of Hepatocellular Carcinoma
Mini-Reviews in Medicinal Chemistry Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Current Aging Science